0001415889-23-016914.txt : 20231222
0001415889-23-016914.hdr.sgml : 20231222
20231222180538
ACCESSION NUMBER: 0001415889-23-016914
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231221
FILED AS OF DATE: 20231222
DATE AS OF CHANGE: 20231222
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Gilliam Joseph E
CENTRAL INDEX KEY: 0001705850
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37463
FILM NUMBER: 231511036
MAIL ADDRESS:
STREET 1: C/O GLAUKOS CORPORATION
STREET 2: 229 AVENIDA FABRICANTE
CITY: SAN CLEMENTE
STATE: CA
ZIP: 92677
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: GLAUKOS Corp
CENTRAL INDEX KEY: 0001192448
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 229 AVENIDA FABRICANTE
CITY: SAN CLEMENTE
STATE: CA
ZIP: 92672
BUSINESS PHONE: 949-367-9600
MAIL ADDRESS:
STREET 1: 229 AVENIDA FABRICANTE
CITY: SAN CLEMENTE
STATE: CA
ZIP: 92672
FORMER COMPANY:
FORMER CONFORMED NAME: GLAUKOS CORP
DATE OF NAME CHANGE: 20020925
4
1
form4-12222023_111232.xml
X0508
4
2023-12-21
0001192448
GLAUKOS Corp
GKOS
0001705850
Gilliam Joseph E
C/O GLAUKOS CORPORATION
ONE GLAUKOS WAY
ALISO VIEJO
CA
92656
false
true
false
false
PRESIDENT & COO
1
Common Stock
2023-12-21
4
M
0
25000
41.69
A
145001
D
Common Stock
2023-12-21
4
S
0
4835
83.70
D
140166
D
Common Stock
2023-12-21
4
S
0
16965
84.97
D
123201
D
Common Stock
2023-12-21
4
S
0
3200
85.58
D
120001
D
Stock Option (Right to Buy)
41.69
2023-12-21
4
M
0
25000
0
D
2027-05-05
Common Stock
25000
92044
D
Includes 82,275 restricted stock units that have not yet vested or not yet been delivered to the Reporting Person. Also reflects a prior transfer by the Reporting Person of 88 shares of common stock pursuant a domestic relations order in connection with a marital dissolution.
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 7, 2023.
This transaction was executed in multiple trades at prices ranging from $83.38 to $84.35. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Includes 82,275 restricted stock units that have not yet vested or not yet been delivered to the Reporting Person.
This transaction was executed in multiple trades at prices ranging from $84.44 to $85.43. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $85.44 to $85.71. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
The option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 7, 2023.
This option was granted on May 5, 2017 and had a four-year vesting schedule in which 25% vested on the first anniversary of the grant date and the
remainder vested in equal monthly installments for 36 months thereafter, such that the stock option vested in full on the four-year anniversary of the grant
date.
Diana Scherer, Attorney-in-Fact
2023-12-22